. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Crit Care Med. 2013 Dec;41(12):e439–e446. doi: 10.1097/CCM.0b013e318298ad3a

Table 2.

Wet-to-dry-weight ratio, histological and immunohistochemical analyses

Variable	control	rhATIII	sham
Wet-to-dry-weight ratio	6.0 ± 0.3^#	4.7 ± 0.3^†	4.5 ± 0.1
Obstruction bronchi (score)	13.7 ± 1.9^#	4.8 ± 0.7^†	3.2 ± 1.2
Obstruction bronchioli (score)	3.5 ± 0.8^#	0.8 ± 0.2^†	0.9 ± 0.1
Alveolar edema (score)	1.1 ± 0.3^#	0.3 ± 0.2^†	0.0 ± 0.0
Pulmonary hemorrhage (score)	0.25 ± 0.09^#	0.04 ± 0.04	0.0 ± 0.0
Myeloperoxidase activity (U·mL⁻¹)	12.2 ± 1.5^#	8.4 ± 0.4^#^†	4.0 ± 0.7

, p< .05 vs. sham;

^†

, p< .05 vs. control; each group n = 6

rhATIII, recombinant human antithrombin III; w/d-weight, wet-to-dry-weight ratio